Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-week Exploratory, Multicenter, Double-blind, Vehicle-controlled Study to Investigate the Efficacy and Safety of Topical Azelaic Acid 15% Foam Twice Daily in Patients With Papulopustular Rosacea

NCT00617903 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT00617903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00617903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-week Exploratory, Multicenter, Double-blind, Vehicle-controlled Study to Investigate the Efficacy and Safety of Topical Azelaic Acid 15% Foam Twice Daily in Patients With Papulopustular Rosacea
Lead sponsor
LEO Pharma
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2008
Completion date
June 30, 2008
Enrollment
83 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

papulopustular rosacea